Recent Strategies to Develop Conjugated Polymers for Detection and Therapeutics

Area of Science:

• Biomedical engineering
• Materials science
• Nanotechnology

Background:

• Pathogenic microbes and cancer pose significant threats to public health, with existing treatments facing challenges like drug resistance and severe side effects.
• Antibiotic resistance has diminished the efficacy of conventional antimicrobial therapies.
• Traditional cancer treatments often suffer from recurrence, poor prognosis, and significant toxicity.

Purpose of the Study:

• To review the design strategies and recent advancements in conjugated polymers (CPs) for biomedical applications.
• To explore the application of CPs in the detection and treatment of pathogenic microorganisms and tumors.
• To discuss the limitations and future potential of CPs in biomedicine.

Main Methods:

• Review of recent literature on conjugated polymers in biomedical fields.
• Analysis of CPs' design strategies, focusing on their photoelectric properties and functionalization.
• Categorization of CPs' applications based on detection and treatment methodologies for pathogens and tumors.

Main Results:

• Conjugated polymers (CPs) demonstrate significant potential in both detecting and treating infectious diseases and cancer.
• CPs offer advantages such as ease of modification, good biocompatibility, and low cost, making them versatile for biomedical applications.
• The review highlights diverse applications of CPs in phototherapy and diagnostic tools for various diseases.

Conclusions:

• Conjugated polymers represent a promising class of materials for developing next-generation therapeutic and diagnostic agents.
• CPs offer a viable strategy to combat antibiotic resistance and overcome limitations of traditional cancer therapies.
• Further research into CPs' design and application holds significant potential for advancing public health and medical treatments.